• CTOP in Advanced μ-Opioid Receptor Signaling Inhibition Rese

  2026-06-30

  Explore how CTOP, a potent μ-opioid receptor antagonist, enables unprecedented precision in dissecting opioid signaling pathways. This article reveals unique mechanistic insights and practical assay guidance not covered elsewhere.

• Chloramphenicol in Plasmid Surveillance: Modern Assay Design

  2026-06-29

  Explore chloramphenicol's multifaceted role as an antimicrobial agent and bacterial protein synthesis inhibitor in advanced plasmid surveillance assays. This article uniquely connects molecular protocols with real-world resistance transmission, offering guidance for robust research workflows.

• Cholesterol Impairs Lipid Nanoparticle Trafficking in Cells

  2026-06-29

  This study reveals that elevated cholesterol within lipid nanoparticles (LNPs) hinders their intracellular trafficking, leading to impaired nucleic acid delivery. By dissecting the lipid composition using advanced imaging and a DNA tracking platform, the authors clarify how cholesterol disrupts endosomal escape—a critical step for LNP-based gene delivery.

• 3-Bromopyruvate and Cetuximab Synergy Triggers Ferroptosis i

  2026-06-28

  This study demonstrates that co-treatment with 3-bromopyruvate (3-BP) and cetuximab overcomes resistance in colorectal cancer (CRC) cells by inducing autophagy-dependent ferroptosis and apoptosis. Mechanistic insights reveal that restoration of FOXO3a signaling underpins this effect, suggesting actionable targets for overcoming drug resistance in KRAS/BRAF-mutant and acquired-resistant CRC models.

• PDK4-IN-1 Hydrochloride: Precision PDK4 Inhibition in Metabo

  2026-06-27

  PDK4-IN-1 hydrochloride delivers nanomolar selectivity for pyruvate dehydrogenase kinase 4, enabling rigorous control of mitochondrial energy metabolism in cell-based and animal models. This guide translates advanced findings into practical workflows, troubleshooting, and comparative insights for metabolic, oncological, and cardiac hypertrophy research.

• Flumequine: DNA Topoisomerase II Inhibitor in Cancer Researc

  2026-06-26

  Flumequine enables precise and reproducible DNA topoisomerase II inhibition, transforming DNA replication and drug response assays in oncology and antibiotic resistance research. Its robust solubility and validated inhibition parameters equip researchers for high-fidelity experimental workflows and streamlined troubleshooting.

• Applied nor-NOHA Acetate: Precision Arginase Inhibition Work

  2026-06-26

  nor-NOHA acetate empowers cancer and vascular researchers to precisely probe arginase-linked pathways, modulate nitric oxide production, and dissect complex cell fate decisions. This guide details advanced protocols, troubleshooting strategies, and translational insights for maximizing reproducibility and scientific impact using APExBIO's high-purity nor-NOHA (acetate).

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Quantitative Fidel

  2026-06-25

  Discover how the FITC Goat Anti-Rabbit IgG (H+L) Antibody enables precise, sensitive detection in immunofluorescence assays. This article explores advanced quantitative applications and protocol insights, bridging immunodetection with recent fibrosis research.

• Exemestane in Precision Endocrine Research: Beyond Inhibitio

  2026-06-25

  Explore how Exemestane, a selective steroidal aromatase inhibitor, enables advanced precision in endocrine and breast cancer research. This article uniquely focuses on practical assay considerations and translational insights, offering a deeper scientific perspective.

• 5-Azacytidine: Mechanisms, Evidence & Protocols in Cancer Re

  2026-06-24

  5-Azacytidine (5-AzaC) is a cytosine analogue and potent DNA methyltransferase inhibitor used for DNA demethylation and gene reactivation. It demonstrates efficacy in suppressing metastasis via dormancy induction in cancer models, with benchmarked low micromolar IC50 values against leukemia and myeloma cells. This article details its mechanism, experimental benchmarks, and protocol parameters for advanced epigenetic research.

• Imipenem: Semisynthetic Thienamycin Antibiotic in Research W

  2026-06-23

  Imipenem offers a unique blend of broad-spectrum antibacterial efficacy and immune modulation, making it a cornerstone for advanced antibacterial research. This article details actionable workflows, resistance monitoring strategies, and troubleshooting tips, all anchored in the latest transmission dynamics research.

• Balancing Self-Renewal and Differentiation in Human Intestin

  2026-06-23

  This study introduces a tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation, overcoming previous limitations in cellular diversity and proliferative capacity. The findings have significant implications for high-throughput disease modeling, drug screening, and research on epigenetic regulation in cancer and tissue regeneration.

• Central Circuits in Opioid-Induced Mechanical Hypersensitivi

  2026-06-22

  Yin et al. (2024) dissect a specific brain-to-spinal neural circuit governing morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. Their work clarifies the central control of μ-opioid receptor signaling in pain models, offering a mechanistic basis for targeting opioid side effects.

• Lycopene Shields Intestinal Barrier from DON via ERK Pathway

  2026-06-22

  This study identifies lycopene as a protective agent against deoxynivalenol (DON)-induced intestinal barrier dysfunction and NLRP3 inflammasome activation in vitro, with mechanistic evidence implicating ERK pathway modulation. Findings highlight a potential therapeutic axis for mitigating mycotoxin-induced enterotoxicity in agricultural and biomedical contexts.

• USP42 Drives Breast Cancer Progression via JNK/p38 Apoptosis

  2026-06-21

  This study establishes USP42 as a key driver of breast cancer progression through its suppression of JNK/p38-mediated apoptosis. By dissecting USP42’s mechanistic role using molecular, cellular, and in vivo models, the research highlights new therapeutic targets for breast cancer intervention.

16341 records 1/1090 page Next 12345 下5页 Last page